Food and Drug Regulations
Version of section C.04.129 from 2006-03-22 to 2025-06-30:
C.04.129 Poliovirus vaccine, live, oral, shall be fabricated, packaged/labelled and tested in premises separated from buildings where other products are fabricated, packaged/labelled or tested, and from buildings where control tests involving the use of cell lines or virus strains not employed in the fabrication, packaging/labelling and testing of poliovirus vaccine, live, oral, are carried out.
- SOR/97-12, s. 45
Page Details
- Date modified: